Radiation oncologist Jamie Takayesu, MD, recently joined the Fred Hutch proton therapy team.
Takayesu completed her residency in radiation oncology at the University of Michigan, Ann Arbor, and will be focusing on treating patients with gastrointestinal cancers, such as liver, pancreas and rectal cancers, as well as prostate and other genitourinary cancers.
She’s especially excited about using proton therapy in patients needing reirradiation, and to treat liver cancers in patients with poor liver function.
“For cancers of the liver, the use of protons can really make a difference in treatment outcomes,” Takayesu said. “Often, liver cancer patients have concurrent cirrhosis, which means sparing healthy tissue is even more important.”
Takayesu grew up in Hawaii before she came to the contiguous U.S. for her education and she chose to study oncology after a family member was diagnosed with cancer when she was young. When she learned about radiation oncology in medical school, she realized what a powerful tool it can be to treat cancer and to alleviate cancer symptoms to improve patients’ quality of life.
Though she is engaged in multiple lines of research, Takayesu has a special interest in the interplay between gender and cancer care. She studied the differences in how health care providers approach sexual function for women versus men.
“There is a tangible difference in how health care providers discuss sexual function with women and men, and an even bigger difference in how we quantify and manage their sexual dysfunction after cancer treatments,” she said, pointing to patient questionnaires that frequently ask men about sexual dysfunction, but not women.
"For men, there are multiple medications to help with erectile dysfunction," she said, "but for women, interventions generally include pelvic floor therapy and cognitive behavioral therapy, which are much more time-intensive. They also create a much larger barrier for women to receive appropriate therapy for sexual dysfunction.”
She has also investigated how gendered expectations in the workplace and at home disproportionately impact woman physician-scientists, leading to feelings of guilt and burnout, and which could in part explain why women are still underrepresented in leadership roles in medicine.
Currently, she is doing a meta-analysis regarding the use of different androgen deprivation therapy (ADT) medications during radiation therapy. She's also investigating long-term outcomes and effects of radiation in breast cancer and other disease sites.
Her work leaves little time to do other things, Takayesu said, but she does enjoy reading classic literature, as well as playing golf.
Please welcome Takayesu when you see her at the proton therapy facility.